Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL180010 |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| 5-HT1A receptor/5-hydroxytryptamine receptor 1A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL214] [GtoPdb: 1] [UniProtKB: P08908] | ||||||||
| ChEMBL | Binding affinity to human 5HT1A receptor | B | 7.07 | pKi | 85.4 | nM | Ki | J Med Chem (2007) 50: 4135-4146 [PMID:17672446] |
| 5-HT2A receptor/5-hydroxytryptamine receptor 2A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL224] [GtoPdb: 6] [UniProtKB: P28223] | ||||||||
| ChEMBL | Binding affinity to human 5HT2A receptor | B | 7.2 | pKi | 62.4 | nM | Ki | J Med Chem (2007) 50: 4135-4146 [PMID:17672446] |
| 5-HT2C receptor/5-hydroxytryptamine receptor 2C in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL225] [GtoPdb: 8] [UniProtKB: P28335] | ||||||||
| ChEMBL | Binding affinity to human 5HT2C receptor | B | 7.33 | pKi | 47 | nM | Ki | J Med Chem (2007) 50: 4135-4146 [PMID:17672446] |
| D2 receptor/D(2) dopamine receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL217] [GtoPdb: 215] [UniProtKB: P14416] | ||||||||
| ChEMBL | Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells | B | 6.97 | pKi | 106 | nM | Ki | J Med Chem (2005) 48: 3663-3679 [PMID:15916415] |
| ChEMBL | Binding affinity for human dopamine D2 receptor | B | 7.03 | pKi | 93.3 | nM | Ki | J Med Chem (2005) 48: 839-848 [PMID:15689168] |
| ChEMBL | Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells | B | 7.03 | pKi | 93.3 | nM | Ki | J Med Chem (2005) 48: 3663-3679 [PMID:15916415] |
| ChEMBL | Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells | B | 7.03 | pKi | 93.3 | nM | Ki | J Med Chem (2007) 50: 4135-4146 [PMID:17672446] |
| ChEMBL | Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting | B | 7.03 | pKi | 93.3 | nM | Ki | J Med Chem (2011) 54: 3581-3594 [PMID:21495689] |
| ChEMBL | Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells | B | 7.13 | pKi | 74 | nM | Ki | J Med Chem (2015) 58: 5361-5380 [PMID:25826710] |
| ChEMBL | Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor | F | 7.09 | pIC50 | 80.9 | nM | IC50 | J Med Chem (2005) 48: 3663-3679 [PMID:15916415] |
| ChEMBL | Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay | F | 7.09 | pIC50 | 80.9 | nM | IC50 | J Med Chem (2007) 50: 4135-4146 [PMID:17672446] |
| D3 receptor/D(3) dopamine receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL234] [GtoPdb: 216] [UniProtKB: P35462] | ||||||||
| ChEMBL | Inhibition of [3H]YM-09151-2 binding to human Dopamine D3 receptor expressed in CHO cells | B | 8.68 | pKi | 2.11 | nM | Ki | J Med Chem (2005) 48: 3663-3679 [PMID:15916415] |
| ChEMBL | Binding affinity for human dopamine D3 receptor | B | 9.15 | pKi | 0.7 | nM | Ki | J Med Chem (2005) 48: 839-848 [PMID:15689168] |
| ChEMBL | Inhibition of [125I]IABN binding to human Dopamine D3 receptor expressed in HEK 293 cells | B | 9.15 | pKi | 0.7 | nM | Ki | J Med Chem (2005) 48: 3663-3679 [PMID:15916415] |
| ChEMBL | Displacement of [125I]IABN from human dopamine D3 receptor expressed in HEK293 cells | B | 9.15 | pKi | 0.7 | nM | Ki | J Med Chem (2007) 50: 4135-4146 [PMID:17672446] |
| ChEMBL | Displacement of [125I]-IABN from human dopamine D3 receptor expressed in HEK293 cells after 60 mins by gamma counting | B | 9.15 | pKi | 0.7 | nM | Ki | J Med Chem (2011) 54: 3581-3594 [PMID:21495689] |
| GtoPdb | - | - | 9.2 | pKi | - | - | - | J Med Chem (2007) 50: 4135-46 [PMID:17672446] |
| ChEMBL | Displacement of [3H]N-methylspiperone from human dopamine D3 receptor expressed in HEK293 cells | B | 9.5 | pKi | 0.32 | nM | Ki | J Med Chem (2015) 58: 5361-5380 [PMID:25826710] |
| ChEMBL | Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D3 receptor | F | 8.52 | pIC50 | 3.01 | nM | IC50 | J Med Chem (2005) 48: 3663-3679 [PMID:15916415] |
| ChEMBL | Antagonist activity at human dopamine D3 receptor expressed in HEK293 cells by mitogenesis assay | F | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (2007) 50: 4135-4146 [PMID:17672446] |
| D4 receptor/D(4) dopamine receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL219] [GtoPdb: 217] [UniProtKB: P21917] | ||||||||
| ChEMBL | Displacement of [3H]N-methylspiperone from human dopamine D4 receptor expressed in HEK293 cells | B | 6.26 | pKi | 550 | nM | Ki | J Med Chem (2015) 58: 5361-5380 [PMID:25826710] |
| ChEMBL | Binding affinity for human dopamine D4 receptor | B | 6.43 | pKi | 375 | nM | Ki | J Med Chem (2005) 48: 839-848 [PMID:15689168] |
| ChEMBL | Inhibition of [125I]IABN binding to human Dopamine D4 receptor expressed in HEK 293 cells | B | 6.43 | pKi | 375 | nM | Ki | J Med Chem (2005) 48: 3663-3679 [PMID:15916415] |
| ChEMBL | Displacement of [125I]IABN from human dopamine D4 receptor expressed in HEK293 cells | B | 6.43 | pKi | 375 | nM | Ki | J Med Chem (2007) 50: 4135-4146 [PMID:17672446] |
| ChEMBL | Displacement of [125I]-IABN from human dopamine D4 receptor expressed in HEK293 cells after 60 mins by gamma counting | B | 6.43 | pKi | 375 | nM | Ki | J Med Chem (2011) 54: 3581-3594 [PMID:21495689] |
ChEMBL data shown on this page come from version 36:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]